copd	is a	chronic inflammatory lung disease
bronchiectasis	is a	chronic suppurative lung disease
copd	is characterized by	airway inflammation
copd	coexists with	bronchiectasis
bronchiectasis	coexists with	copd
smoking	is a risk factor for	copd
air pollution	is a risk factor for	copd
age	is a risk factor for	copd
alpha-1 antitrypsin deficiency	predisposes to	copd
age	increases	copd risk
pseudomonas aeruginosa colonization	is observed in	bronchiectasis
airway clearance techniques	improve	sputum clearance
inhaled corticosteroids	associated with	pneumonia risk
pneumonia	leads to	hospitalization
exacerbation	increases	mortality risk
copd	is treated with	bronchodilators
bronchodilators	improve	airflow
inhaled corticosteroids	reduce	copd exacerbations
bronchiectasis	is characterized by	mucus hypersecretion
mucus hypersecretion	contributes to	bacterial colonization
bacterial colonization	predisposes to	exacerbation
exacerbation	requires	antibiotics
antibiotics	treat	bacterial infection
pseudomonas aeruginosa	associated with	worse copd prognosis
pseudomonas aeruginosa	associated with	bronchiectasis severity
airway clearance therapy	improves	mucus clearance
bronchiectasis	increases	sputum production
bronchiectasis	increases	risk of hemoptysis
hemoptysis	requires	imaging
ct scan	detects	bronchiectasis
spirometry	measures	airway obstruction
oxygen therapy	needed in	chronic hypoxemia
chronic hypoxemia	leads to	pulmonary hypertension
pulmonary hypertension	increases	mortality risk
copd	is comorbid with	cardiovascular disease
copd	is comorbid with	diabetes
copd	is comorbid with	osteoporosis
osteoporosis	increases	fracture risk
bronchiectasis	is associated with	chronic infection
chronic infection	promotes	neutrophilic inflammation
neutrophilic inflammation	contributes to	tissue damage
smoking	accelerates	lung function decline
lung function decline	predicts	mortality
emphysema	coexists with	copd
bronchial hyperreactivity	present in	copd
airflow limitation	defines	copd
alpha-1 antitrypsin deficiency	causes	early-onset copd
ct scan	detects	bronchiectasis
bronchiectasis	leads to	sputum purulence
sputum purulence	indicates	bacterial infection
antibiotics	prescribed for	copd exacerbations
macrolide antibiotics	reduce	copd exacerbations
vaccination	protects against	influenza
influenza	triggers	copd exacerbations
influenza vaccination	reduces	hospitalization
bronchiectasis	causes	recurrent infections
recurrent infections	lead to	lung damage
lung damage	worsens	gas exchange
gas exchange	declines with	disease progression
pseudomonas infection	associated with	worse bronchiectasis outcomes
antibiotic therapy	reduces	bacterial load
nebulized antibiotics	used for	chronic pseudomonas infection
chest physiotherapy	aids	mucus clearance
exacerbation risk	increases with	air pollution exposure
air pollution exposure	increases	copd exacerbations
nutrition status	affects	copd prognosis
physical activity	improves	exercise tolerance
exercise tolerance	predicts	quality of life
bronchodilator therapy	improves	dyspnea
dyspnea	leads to	reduced mobility
pulmonary rehabilitation	improves	exercise capacity
pulmonary rehabilitation	reduces	hospitalization risk
sputum culture	guides	antibiotic selection
multidrug-resistant organisms	complicate	bronchiectasis management
hrct findings	indicate	bronchiectasis
cystic fibrosis	is associated with	bronchiectasis
bronchodilator	used with	inhaled corticosteroid
nebulized hypertonic saline	used for	bronchiectasis
sputum culture	reveals	pseudomonas aeruginosa
copd	colonized by	pseudomonas aeruginosa
bronchiectasis	predisposes to	colonization
colonization	sustains	chronic infection
respiratory failure	risk increases with	copd
respiratory failure	risk increases with	bronchiectasis
oxygen saturation	correlates with	prognosis
readmission	risk increases with	copd exacerbation
sputum color	indicates	bacterial infection
bronchiectasis	often requires	long-term antibiotics
long-term antibiotics	reduce	exacerbation frequency
exacerbation frequency	correlates with	hospitalization rate
hospitalization rate	increases	healthcare burden
healthcare burden	rises with	chronic lung disease
oxygen saturation	measured by	pulse oximetry
blood gas analysis	informs	hypoxemia severity
hypoxemia severity	guides	oxygen therapy
vaccination	reduces	influenza-related hospitalizations
antibiotic resistance	emerges with	chronic antibiotic use
antibiotic stewardship	improves	outcomes
airway remodeling	occurs in	copd
airway remodeling	contributes to	airflow limitation
